FDANews
FDAnews Drug Daily Bulletin

Baxter Wins FDA Clearance of Clindamycin Injection

June 16, 2017

The FDA has cleared Baxter’s ready-to-use clindamycin injection in saline in three prescribed formulations (300mg/50mL, 600mg/50mL, 900mg/50mL).

Clindamycin injection in saline provides an alternative to administer to patients for whom the use of dextrose is contraindicated or undesirable.

Baxter’s ready-to-use clindamycin injection in saline is now available in the U.S.

View today's stories